CytoDyn Inc. (CYDY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 05-31. Amounts in USD.

Revenue Annual

0 100K 200K 300K FY21: 0 FY22: 266K FY23: 0 FY21 FY22 FY23

Gross Profit Annual

0 80K 160K 240K FY22: 213K FY22

Operating Income Annual

-150M -100M -50M 0 50M 100M 150M FY16: -21.2M FY17: -27.3M FY18: -45.9M FY19: -55.9M FY20: -74.6M FY21: -104.6M FY22: -145.4M FY23: -40.6M FY24: -18.1M FY25: 9.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-240M -160M -80M 0 80M 160M 240M FY16: -25.7M FY17: -25.8M FY18: -50.1M FY19: -56.2M FY20: -139.9M FY21: -176.5M FY22: -210.8M FY23: -79.8M FY24: -49.8M FY25: 3.7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 20K 40K 60K FY22: 53K FY22

Operating Cash Flow Annual

-120M -80M -40M 0 40M 80M 120M FY16: -24.8M FY17: -26.7M FY18: -29.9M FY19: -50.5M FY20: -68.8M FY21: -117.6M FY22: -77.7M FY23: -25.1M FY24: -11M FY25: -8.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-150M -100M -50M 0 50M 100M 150M FY11: -1.8M FY13: -3.4M FY14: -7.4M FY15: -12M FY16: -24.8M FY17: -26.7M FY18: -29.9M FY19: -50.5M FY20: -68.8M FY21: -117.7M FY11 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 500M 1B 1.5B FY20: 421.1M FY21: 587.6M FY22: 676.9M FY23: 836.5M FY24: 969.5M FY25: 1.2B FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q2 '17: -0.27 Q3 '17: -0.28 Q4 '17: -0.29 Q1 '18: -0.21 Q2 '18: -0.19 Q3 '18: -0.23 Q4 '18: -0.22 Q1 '19: -0.26 Q2 '19: -0.29 Q3 '22: -0.31 Q4 '22: -0.31 Q1 '23: -0.27 Q2 '23: -0.24 Q3 '23: -0.20 Q4 '23: -0.10 Q1 '24: -0.08 Q2 '24: -0.06 Q3 '24: -0.05 Q4 '24: -0.04 Q1 '25: -0.01 Q2 '25: -0.00 Q3 '25: 0.01 Q4 '25: 0.00 Q1 '26: -0.02 Q2 '26: -0.04 Q3 '26: -0.04 Q3 '17 Q3 '18 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.